The features of male breast cancer in China: A real-world study

Yuxuan Gao(Sun Yat-sen University), Ying Lin(Sun Yat-sen University), Zhenhai Cai(Jiaxing University), Chenglei Zhang(Guangdong University Of Finances and Economics), Yu Ren(Chongqing University), Li Ma(National Institute of Standards and Technology), Zhongyu Yuan(University of Wisconsin–Madison), Shu Liu(Guangdong Province Women and Children Hospital), Zefei Jiang, Ling Xu(Peking University), Weiwen Li(Jiangmen Central Hospital), Songqing Ye(Fujian Provincial Hospital), Zhenzhen Liu(Zhengzhou University), Wei Wei(Peking University Shenzhen Hospital), Xinxin Chen(First Affiliated Hospital of Wenzhou Medical University), Qiang Liu(Sun Yat-sen University), Bo Chen(Capital Medical University), Yali Cao(Third Hospital of Nanchang), Baoliang Guo(Harbin Medical University), Jianyun Nie(Kunming Medical University), Zhiyong Wu(Nanfang Hospital), Gang Sun(Xinjiang Medical University), Xiaoming Zha(Nanjing Medical University), Juan Xu(Guangdong Province Women and Children Hospital), Peifen Fu(First Affiliated Hospital Zhejiang University), Qianjun Chen(Guangzhou University of Chinese Medicine), Heng Huang(Qujiang People's Hospital), Yingying Shi(Institute of Special Animal and Plant Sciences), Jianbin Li(Chinese PLA General Hospital), Yuhua Song(Qingdao University), Kun Wang(Guangdong Academy of Medical Sciences), Mengmeng Zhang(Sun Yat-sen University), Caiwen Du(Chinese Academy of Medical Sciences & Peking Union Medical College), Sihua Liu(Tianjin University), Guolin Ye(First People's Hospital of Foshan), Ting Liu(Qingdao University), Hebing Wang(Sun Yat-sen University)
The Breast
June 22, 2024
10.1016/j.breast.2024.103762
Cited by 10

Related Papers

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021
|Annals of Oncology|2021|799
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|724